BioSpace News Archive

Houston Medical Imaging announced that their outpatient imaging facility will be open to schedule MRIs on their new Ultra High Field 3T MRI GE Pioneer machine

The global myelofibrosis therapeutics market is expected to post a CAGR of over 7% during the period 2018-2022, according to the latest market research report by Technavio.

The Supreme Administrative Court announced its judgment today in Essity’s dispute with the Swedish Tax Agency regarding the agency’s decision to impose additional taxes and tax surcharges for the years 2008 to 2012.

Massachusetts-based Aerodiagnostics™ is pleased to announce the appointment of Dr. Kathleen O’Neil-Smith as its incoming Medical Director.

Frelii Inc. (OTCQB: FRLI) (“Frelii” or “The Company”) today announced that its common shares are now trading on the OTCQB Venture Market (“OTCQB”), a U.S. trading platform operated by OTC Markets Group in New York. The Company will trade under the ticker symbol “FRLI” beginning on December 28, 2018.

CABEI and the Republic of Korea will continue working to make the region sustainable. The entry of Korea into the multilateral organization will attract and channel external resources to the region.

Today the Centers for Medicare & Medicare Services (CMS) recognized the Pathologists Quality Registry as a Qualified Clinical Data Registry (QCDR) for the third consecutive year, making the College of American Pathologists’ (CAP) registry a vital tool for pathologists to demonstrate quality and value, and complete reporting requirements under Medicare’s Quality Payment Program (QPP) Merit-Based Incentive Payment System (MIPS).

Largest dental support organization increases intraoral scanner awareness with first-annual event

eQuine Holdings, a Class II Multi-Family Office, has disclosed an eight percent (8%) equity stake in AngioSoma (OTC-PINK:SOAN).

Kahn Swick & Foti, LLC remind investors that they have until February 19, 2019 to file lead plaintiff applications in a securities class action lawsuit against Dentsply Sirona, Inc. (NasdaqGS: XRAY), if they purchased the Company’s shares between February 20, 2014 and August 7, 2018, inclusive (the “Class Period”).